Long-Term Effectiveness, Safety, and Tolerability of Twice-Daily Dosing with Deferasirox in Children with Transfusion-Dependent Thalassemias Unresponsive to Standard Once-Daily Dosing.
Mediterr J Hematol Infect Dis
; 13(1): e2021065, 2021.
Article
in En
| MEDLINE
| ID: mdl-34804439
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Mediterr J Hematol Infect Dis
Year:
2021
Document type:
Article
Affiliation country:
Tailandia